| (GBp) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 36.99M | 52.67% |
| Operating expense | — | — |
| Net income | -13.14M | -35.80% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, STX.L returned -39.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -50.8% |
| 1 year | -39.8% |
| 5 years | -89.2% |
| 10 years | -96.9% |
| All-time high | GBX 187.49 (Nov 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what £1,000 in STX.L would be worth today ›No. Shield Therapeutics plc has not paid a dividend in the past 12 months.
Shield Therapeutics plc is part of the Healthcare sector.
Shield Therapeutics plc has a market cap of 50.29M GBp, based on the latest quote.
